MRNAModerna, Inc.

Nasdaq modernatx.com


$ 86.95 $ -3.02 (-3.36 %)    

Tuesday, 20-Aug-2024 15:59:50 EDT
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 86.94
$ 90.26
$ 86.93 x 200
-- x --
$ 86.95 - $ 90.26
$ 62.55 - $ 170.47
2,702,786
na
33.38B
$ 0.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sp-500-nasdaq-100-snap-8-day-winning-streak-what-triggered-wall-streets-setback-on-tuesday

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the la...

Core News & Articles

- Reuters 

Core News & Articles

- Reuters 

 fda-set-to-approve-covid-19-vaccines-as-soon-as-this-week-stocks-etfs-to-watch

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer ou...

 pfizer-biontechs-covid-19flu-combo-vaccine-fails-to-meet-key-goal-in-late-stage-study

Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of...

Core News & Articles

- Reuters

Core News & Articles

- Reuters

 jp-morgan-maintains-neutral-on-moderna-lowers-price-target-to-88

JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Neutral and lowers the price target from $96 to $88.

Core News & Articles

- Reuters

Core News & Articles

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Core News & Articles

https://x.com/i/broadcasts/1kvJpbgRNWgKE

 struggling-covid-19-vaccines-from-astrazeneca-biontechpfizer-moderna-cut-incidence-of-arterial-thromboses-that-cause-heart-attacks-strokes-british-study-shows

COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The ...

 long-covid-remains-diagnostic-mystery-diagnosis-remains-elusive-national-institutes-of-health-funded-study-shows

A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating...

Core News & Articles

- Director General

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION